Neurologic findings characteristic of the impending hepatic coma syndrome occur in some cirrhotic patients treated with diuretic agents that may induce potassium losses (1-5). Even when diuretic agents are not employed, hypokalemia may be associated with this syndrome (6-8). Patients demonstrating these signs often improve after treatment with potassium salts. This result of therapy might indicate that potassium deficiency per se is a pathogenetic factor in the impending hepatic coma syndrome (9). Because of the extensive evidence relating abnormalities in nitrogen metabolism to hepatic coma (10), however, it seemed possible that some derangement of nitrogen metabolism might be associated with potassium deficiency.
Neurologic findings characteristic of the impending hepatic coma syndrome occur in some cirrhotic patients treated with diuretic agents that may induce potassium losses (1) (2) (3) (4) (5) . Even when diuretic agents are not employed, hypokalemia may be associated with this syndrome (6) (7) (8) . Patients demonstrating these signs often improve after treatment with potassium salts. This result of therapy might indicate that potassium deficiency per se is a pathogenetic factor in the impending hepatic coma syndrome (9) . Because of the extensive evidence relating abnormalities in nitrogen metabolism to hepatic coma (10), however, it seemed possible that some derangement of nitrogen metabolism might be associated with potassium deficiency.
This hypothesis, relating potassium deficiency indirectly to the hepatic coma syndrome by an influence this cation has on ammonium metabolism, provided the rationale for undertaking this investigation. The relation of potassium to ammonium metabolism was studied in patients with cirrhosis of the liver and ascites rendered acutely potassium deficient by a diuretic regimen. The results of these studies demonstrate that metabolism of ammonium by the kidney is altered in potassium-deficient patients and that significant quantities of ammonium may be delivered to the cir-culating blood from this source. The findings are interpreted in relation to a role of potassium deficiency in the pathogenesis of the hepatic coma syndrome and to the influence of this cation in the regulation of ammonium metabolism by the kidney.
MATERIALS AND METHODS
Ten patients with cirrhosis of the liver, ascites, and, in some cases, edema were studied in the metabolic ward of the Cleveland Metropolitan General Hospital. Each, except R.C. and A.K., had a history of excessive intake of alcoholic beverages associated with inadequate food intake. All patients had obvious clinical and laboratory evidence for the presence of advanced hepatic cirrhosis. Examination of liver tissue obtained by needle biopsy or at necropsy warranted a diagnosis of Laennec's cirrhosis in R.H., F.F., W.W., and G.S., and of postnecrotic cirrhosis in A.K. and R.C. A.K. and W.W. had additional clinical diagnoses of compensated, arteriosclerotic heart disease and chronic renal disease. W.W. had intermittent 1 to 2+ proteinuria, and examination of kidneys at autopsy revealed a healed focal pyelonephritis. All patients were mentally clear and free of neurologic signs of impending hepatic coma at the time the studies were initiated, although E.H., W.D., and E.N. had demonstrated such signs earlier during their hospitalizations.
Patients were ambulatory within the metabolic ward. Food and fluid intakes were constant during and for 6 days before each patient study. Fluid intakes ranged from 1,000 to 2,500 ml daily. The constant diets provided 1,800 to 2,500 calories, 46 to 75 g protein daily, and contained 7 to 11 mEq sodium and 52 to 90 mEq potassium. The compositions of the diets used were calculated from standard reference materials (11) (12) (13) (14) (15) .
Each study consisted of: a) a 1to 3-day control period: b) 4 days of oral calcium chloride administration; c) the intramuscular administration of a mercurial diuretic (Thiomerin,1 2 ml) on the morning of day 4 of calcium chloride administration; in 11 of the 22 studies, followed after 1 hour by the slow (within 10 to 15 minutes) intravenous administration of 0.5 g of aminophylline; and d) a recovery period.
Patients were weighed daily under constant conditions before breakfast. Urine samples were kept at 4°C with 10 ml of 10: 1 mixture of glacial acetic acid and 1 Mercaptomerin sodium.
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RENAL AMMONIUM METABOLISM IN POTASSIFUM DEPLETION toluol as preservative until completion of each daily collection. Total volumes were then measured and suitable samples stored at -200 C for subsequent analysis. For R.C. and E.N., urine specimens were collected under oil and thymol as preservative and stored at 40 C until completion of each day's collection when pH was determined. Then total volumes were measured, glacial acetic acid was added as preservative, and samples were stored at -200 C.
Samples of arterial blood were obtained from fasted patients as follows: a) during the control period and on day 1 of calcium chloride, but prior to its administration; b) on the day the diuretic was given; c) daily in the early recovery period; and d) then at suitable intervals. Blood samples were obtained in separate syringes for determinations of ammonium nitrogen, electrolytes, and pH. Blood for ammonium nitrogen analyses was transferred to Conway dishes immediately after shedding. Blood for pH was obtained anaerobically in heparinized syringes and analyzed immediately. Blood for electrolyte determinations was allowed to clot for 45 minutes after shedding and then centrifuged. The sera were separated promptly and stored at -200 C until analyzed. Electrocardiographic tracings were recorded before and a day after the induction of a diuresis.
In addition to arterial and peripheral venous blood samples, blood was obtained from the right renal vein and hepatic vein in four patients and from the jugular bull) in three patients by application of cardiac catheterization techniques. Each of these patients received 64 mg phenobarbital orally at bedtime the night before and 50 mg sodium pentobarbital orally at 8:00 a.m. the morning of the catheterization procedure. At 8 :30 a.m. the patient w d as taken to the cardiovascular laboratories. A solution of 5% glucose in water, containing 50 mg heparin per L, was run slowly through the catheter. About 500 ml of this solution was used for each catheterization. F.F. received saline instead of glucose solution for his first catheterization. Placing of the catheter in the right renal vein was determined by direct fluoroscopic visualization and by the "arterialized" appearance of the venous blood. The differences in oxygen content between peripheral artery and renal vein were determined, and in all instances were less than 2.0 vol per 100 ml. F.F. was catheterized after 3 days of calcium chloride administration and again about 72 hours after the induction of the mercurial diuresis. W.D. and E.N. were catheterized after two days of calcium chloride loading and again 48 hours after administration of the diuretic. The one catheterization for R.C. was done about 48 hours after the mercurial diuretic was given. Arterial blood samples were obtained for ammonium nitrogen determinations simultaneously with each sample of renal venous blood. At the time of collection of renal venous blood for ammonium nitrogen determination, samples for analysis of potassium content and pH were obtained, and within a few minutes, arterial blood was also obtained for these determinations. During the one catheterization procedure in R.C., and the second procedures in \V.D. and E.N., potassium gluconate (0.25 At solution, pH 7.00) was infused through the exploring catheter as recorded with each patient's data (Tables IV and V) . Immediately after the infusion was completed, blood samples were again obtained from artery and renal vein. Peripheral venous blood was obtained simultaneously with renal venous blood for determination of ammonium nitrogen concentration. E.N. was given 60 mmoles of glucose (200 ml of 5%c glucose in distilled water) in 40 minutes during his first catheterization as a control study.
Fractional urine samples were collected through indwelling catheters before and during potassium gluconate administration in E.N. and R.C. and also before and during the glucose infusion in E.N. Continuous electrocardiographic tracings were made during the infusions of potassium. Potassium was given until the T waves, which had become abnormal after the diuresis, clearly became normal. After the catheterization procedure was completed, the patient was returned to the metabolic unit, and the constant regimen was resumed with minimal disruption, except for the unavoidable alteration in times of feeding. Each 24-hour urine sample was analyzed for total nitrogen content by the Kjeldahl method (16) . Serum urea nitrogen was determined by the method of Owings and Mandel (17) . Serum and urine sodium and potassium concentrations were determined by flame photometry (18) , and chloride concentrations by Sendroy's technique (19) in all patients except R.C. and E.N. For these two patients, urine and sera samples were analyzed for chloride content by the amperometric method devised by Cotlove, Trantham, and Bowman (20) .
Blood and urine ammonium nitrogen concentrations were measured by a modification of the Conway microdiffusion technique (21) (22) (23) . Urine pH and pH of blood were determined anaerobically at 370 C either with a Beckman model G or with a Cambridge pH meter (research model).
RESULTS
Response to diuretic regimien. Data demonstrating the effects of oral calcium chloride administration and the mercurial diuretic on complete blood and urine electrolyte patterns are not presented, since the metabolic alterations resulting from these agents are well-known. The calcium chloride produced a metabolic acidosis with increases in serum chloride concentration and decreases in blood pH. The renal responses of these latients to the induced acidosis, in general, compared to those noted for normal individuals in regard to ammonium excretion (24) . Their excretions of sodium in response to acid loading compared to those that occur in normal individuals depleted of sodium or fed sodium-restricted diets (25. 26) . t Each patient, except A.K., was given 200 mEq of chloride on each of these days as a solution of calcium chloride containing 1 or 2 mEq per All patients exhibited a diuretic response to the mercurial diuretic given intramuscularly on day 4 of calcium chloride administration. Increases in urine volume ranged from 1.4 to 6.1 L and averaged about 3.5 L. The diureses were reflected by decreases in body weight ranging from 1.6 to 6.5 kg, averaging 3.7 kg for the group. On the day of the diuresis, marked increases in the urinary excretion of chloride, sodium, and potassium and a continuing increase in ammonium excretion occurred. During the subsequent days of recovery, losses of body weight were sustained, and urine volumes approximated control values.
After a diuresis, especially if in excess of 3 L of urine, patients frequently complained of anorexia, muscular weakness, and fatigability. Decreased audible peristalsis with gaseous abdominal distention sometimes occurred. Constipation was a relatively frequent complaint. E.H. also showed diminution in peripheral tendon reflexes after each diuresis, and exhibited signs and symptoms of impending hepatic coma including changes in mental status, flapping tremor, and electroencephalographic pattern.
Electrocardiographic tracings were made on the day of the diuresis and on the following day. Sig-nificant depression in the ST segment and flattening of the T waves often occurred within 24 hours. In some patients these electrocardiographic changes were apparent within 4 to 6 hours after the administration of the diuretic agent. These alterations, interpreted as indicative of changes in potassium metabolism, reverted to normal as serum potassium levels increased during recovery periods, owing either to the potassium contained in the control diet or to supplementation with potassium salts.
Ammonium and potassium metabolism. Reproducibility of arterial blood ammonium nitrogen and serum potassium levels from day to day in fasted alert patients with cirrhosis was determined by evaluating statistically 17 pairs of observations obtained in 9 of the subjects for each of these constituents. The following results were obtained: (Tables I  and II) . Twenty-four hours after the administration of the mercurial diuretic, significant decreases in serum potassium levels and increases in blood ammonium levels were apparent (Tables I and II) . For this day a consistent and significant increment in blood ammonium nitrogen level and decrement in serum potassium concentration occurred in each patient. On day 2 after the diuresis, decreased serum potassium levels were still evident and blood ammonium nitrogen levels were further increased, the latter in most instances reaching maximal elevations on this day. These increments of blood ammonium nitrogen concentrations were highly significant (Table II) .
On the day after the diuresis, urinary excretions of ammonium continued above control values; the excretions of potassium promptly decreased below control levels in most patients. Subsequently the urinary excretion of potassium continued at or below control values and then gradually increased. Urine ammonium excretion remained somewhat elevated for several days, gradually returning to control values. W\ithin 6 days serum potassium levels returned to normal and arterial blood am-monium nitrogen concentrations decreased gradually (Table I) .
Cirrhosis of liver and chronic renal disease. Metabolic data obtained in two patients with cirrhosis of the liver and ascites, W.W. and A.K., who also had chronic renal disease with persisting azotemia, are included in Table I . These data differ in certain respects from those obtained for the other patients. W.W. demonstrated a decreased urinary ammonium excretion in response Table I and the mean  values from the two experiments for E. H., Table III. to calcium chloride administration, and both patients showed a persistence of the increased urinary ammonium excretion produced by this agent. A.K. also had increases in blood urea nitrogen concentrations that were not related to decreases in output of urine and small increases in the excretion of nitrogen in the urine following the diuresis. W.W. was the only patient who did not dem-. onstrate significant increases in arterial blood ammonium concentration following the administration of the mercurial diuretic, although potassium losses were consistently induced during each of four experiments. Otherwise these two patients responded similarly to the patients with cirrhosis of the liver without renal disease.
Effect of oral supplementation with potassium gluconate. Because of the reciprocal relationship noted between blood ammonium and potassium levels, a study was designed to determine the effect of oral potassium supplementation on the alterations in blood and urine electrolytes described above. Patient E.H. was selected for this study because he had on several previous occasions demonstrated neurologic signs of impending hepatic coma after the administration of diuretic agents. The basic plan of the two consecutive studies was comparable to that employed for the other patients - (Table III) .
After each of two diuretic episodes, large amounts of water and electrolytes were excreted, and significant hypokalemia accompanied by increasing arterial blood ammonium concentrations occurred. This patient demonstrated confusion, disorientation, and a flapping tremor following each of these diuretic episodes. On the first occasion, these untoward clinical symptoms of impending hepatic coma were clearly evident on day 2 after the diuresis, increased in severity on day 3, and then gradually subsided over the next 4 days. On the second occasion, the clinical and metabolic patterns were comparable to those noted during the first experiment; distinct untoward clinical symptoms were again evident on day 2 after the diuresis. The administration of 270 mEq of potassium as the gluconate daily for 3 days beginning on postdiuretic day 2 was followed by a prompt return of biochemical alterations and of electrocardiographic pattern to normal. Clinical symptoms did not progress after potassium was given, and neurologic status returned to normal in 3 days. Potassium administration corrected the potassium deficit induced by the diuretic regimen. Resulting increases in serum potassium levels were accompanied by decreases in arterial blood ammonium levels. The rate of decrease of blood ammonium level was greater when * These patients were studied during diuretic regimes similar to those employed for the other patients, and they demonstrated comparable blood and urine electrolyte changes. The blood samples for analyses were obtained before and shortly after the infusions. Collections of urine were made for the period just preceding and the period during the infusions of potassium gluconate and glucose. The data pertaining to patient R.C. were obtained on day 2 after the induction of mercurial diuresis. The study involving the glucose infusion in patient E.N. was done the day before the mercurial diuretic was given; the K gluconate study was done on day 2 after the diuresis. supplemental potassium was given than during the control experiment. The pattern of urinary ammonium excretion in the postdiuretic period (Table III, experiment 1) was comparable to that noted in the other patients. The administration of potassium orally (Table III , experiment 2) resulted in more prompt decreases in urinary ammonium excretion to below control values. Unfortunately, urine pH determinations were not done.
Venous catheterization studies. Four patients were studied by venous catheterization techniques (Tables IV and V) . Renal venous blood ammonium levels during the initial catheterizations were about 50%o higher than arterial levels.
Whether or not the administration of calcium chloride influenced the renal venous blood ammonium levels obtained for these patients cannot be determined from the data presented. The differences noted, however, between peripheral artery and renal vein are comparable to those reported by other investigators for normal individuals and for patients with liver disease who were not subjected to acid loading (27) (28) (29) . In addition, as noted above, the administration of calcium chloride orally had no measurable effect upon arterial blood ammonium concentrations. In these patients, the mercurial diuretic also caused large diureses, losses of electrolytes. hypokalemia, and elevations of arterial blood ammonium levels. The renal venous ammonium levels increased after the diuresis by greater increments than arterial levels. The most striking changes were evident in patient W.D. (Table IV) , who, after the diuresis, demonstrated a 50% decrease in serum potassium concentration, a twofold increase in arterial blood ammonium level, and a fourfold increase in renal venous ammonium level. When 60 mEq of potassium gluconate was given intravenously to W.D. during a 30-minute period, decreases in renal venous and arterial blood ammonium levels occurred in the absence of any change in arterial blood pH.
The immediate effects of potassium gluconate infusions were studied in two additional patients (Table V) . The study of patient R.C. was done on day 2 after the induction of a diuresis by the mercurial agent. The administration of potassium gluconate, 30 mEq intravenously in about an hour, was followed by a decrease in the am-monium content of renal venous blood and an increase in blood potassium concentration. The pH of arterial and of renal venous blood decreased. A similar study done with patient E.N., involving the administration of 60 tnEq potassium gluconate in about an hour, yielded a similar result. Decreases in arterial and antecubital venous ammonium levels were also apparent. There were no significant changes in pH of arterial or of renal venous blood. During the studies of these two patients, urine was collected for the periods preceding and accompanying the infusions of potassium gluconate. In both patients during the infusion of potassium, excretion of ammonium decreased, urine pH decreased, and excretion of potassium increased.
When technically possible, antecubital and hepatic venous and jugular bulb blood samples were also obtained during the catheterization procedures. In no instance did ammonium levels in blood samples obtained from these sites significantly exceed arterial levels during the initial catheterization studies or those done while the patients were potassium deficient. Extremities, liver, and brain were, therefore, not contributing ammonium to the arterial circulation before or during the potassium-deficiency state. The influence of potassium deficiency on the metabolism of ammonium by gut could not be evaluated by the experimental techniques employed; at least the ammonium levels in hepatic venous blood provided no evidence for increased shunting of ammonium through the liver from the portal system. An additional control study was done with patient E.N. (Table V) . On the day before the administration of the diuretic agent, this patient was given 60 mmoles of glucose intravenously in about an hour. Although adequate rates of urine flow were not obtained, this study demonstrates that the administration of glucose under technical and mechanical conditions simulating those in the later experiment involving potassium administration did not produce significant alterations in the blood or urine constituents measured. The pH of the urine increased slightly during the glucose infusion. Although the glucose infusion was given in metabolic circumstances that differed from those at the time potassium gluconate was given, the data obtained demonstrate that the changes attributed to potassium gluconate administration were not due to an effect of the catheterization l)rocedure itself.
DISCUSSION
The metabolic responses of patients with cirrhosis of the liver and ascites to acidosis resulting from oral administration of calcium chloride and acute potassium deficiency induced by a mercurial diuresis were evaluated. The results bear on the role of the kidney as a source of blood ammonium in patients with cirrhosis of the liver and on changes in renal ammonium metabolism that occur in l)otassium-deficient patients. The data are interpreted from these points of view.
Ammonium excretion by the kidney was increased in conjunction with the acidosis resulting from calcium chloride. This increase was unaccompanied by change in arterial blood ammonium level. The increasing urinary ammonium excretion apparently did not take place at the expense of, nor result in, detectable elevation of arterial blood ammonium levels. As pointed out in previous publications, the induction of metabolic acidosis per se does not result in ammonium overloading syndromes in patients with liver disease (6, 30) .
The administration of the mercurial diuretic, with or without aminophylline, following acid loading with calcium chloride consistently caused a significant diuresis that in some instances was massive. The urinary excretions of potassium associated with the diureses entailed significant losses of intracellular potassium, since their magnitudes were larger than could possibly have originated from extracellular fluid. A relation between serum potassium and arterial blood ammonium levels was evident in the recovery period following the diuretic regimen; decreased potassium levels were related to elevated ammonium concentrations. In the immediate postdiuretic period, decreases in serum potassium levels were usually evident before increases in arterial blood ammonium concentrations occurred; on the other hand, increases in serum potassium preceded decreases in blood ammonium concentrations during recovery. These changes in arterial blood ammonium levels occurred in the absence of any alteration in exogenous nitrogen load, indicating that the increased quantities of ammonium found in the circulation were originating from an internal source. The above conclusion was further supported by the study of patient E.H. (Table III) . In this study, on two consecutive occasions, blood ammonium concentrations increased as hypokalemia developed following the diuretic regimen. The oral administration of potassium gluconate during the second occasion increased the rate at which arterial blood ammonium levels returned toward control and at which urinary ammonium excretion decreased after the diuresis. This effect of potassium in simultaneously decreasing blood and urine ammonium levels suggested that metabolism of ammonium by the kidney was altered with potassium deficiency. Accordingly, the kidney was considered a possible source of the increased circulating ammonium. This hypothesis was supported by the results of the catheterization experiments. In the potassium-deficient patients, renal venous blood ammonium content was increased as compared to values obtained during or after the development of the acidosis. The magnitude of these increases was consistently greater than that noted in arterial or antecubital venous blood. Determination of ammonium concentrations in antecubital and hepatic venous and jugular bulb blood demonstrated that extremities, liver, and brain were not contributing ammonium to the arterial circulation. The decreases in renal venous and arterial blood ammonium levels that resulted from administration of potassium salts orally further demonstrated that the changes were related to potassium deficiency. The decreases in renal venous and arterial blood ammonium levels resulting from potassium administration were not attributable to a diversion of ammonium from blood to urine, since urinary ammonium excretions were not increased. Thus, the mechanisms involved here are apparently different from those that occur after the administration of acetazolamide. This agent produces a bicarbonate diuresis, prompt increase in urine pH, and diversion of ammonium from urine into renal venous outflow (29) .
The effects of potassium gluconate infusions on renal ammonium metabolism deserve further comment. Ammonium excretion into the urine is related to the pH gradient between tubular cell and urine; as pH decreases, ammonium content increases (31) . This relation did not apply in the two patients studied (Table V) . With adminis-tration of potassium gluconate, urine pH decreased, but the excretion of ammonium also decreased. Similar changes in urinary excretion of ammonium independent of changes in urine pH occur during repletion of patients with chronic potassium deficits resulting from chronic diarrhea (32) . The decrease in ammonium excretion might result from one of several possible mechanisms. Diversion of ammonium from urine to renal venous outflow may occur; the concomitant decreases in renal venous blood ammonium content eliminate this possibility. Although measurements of renal blood flow were not made, the possibility that alterations in this parameter might account for the observed changes seems remote. Considering the magnitude of observed decreases in the rate of urinary ammonium excretion, we estimated that renal blood flow would have had to increase at least two to three times to account for the decreases in renal venous blood ammonium content, assuming constant rates of production and availability. Occurrence of a decrease in renal blood flow would not negate the interpretation of the data presented here. Alterations in the competition of hydrogen and potassium for tubular secretion that might result from potassium administration seem unlikely because the urine did not become alkaline. Whether or not our patients suffered impairment of some tubular functions related to the potassium deficiency cannot be stated. The concomitant decreases in urinary ammonium excretion and renal venous blood ammonium concentrations resulting from potassium administration suggest that potassium influences renal ammonium metabolism by altering production of ammonia by the tubular cells, or by affecting the diffusion or transport of ammonia (or ammonium) from the cells to tubular urine independent of pH gradients.
These results obtained in our study provide evidence that renal production of ammonia or availability of this ion is increased in potassiumdeficient patients, although the exact source and the role of potassium in its regulation cannot be stated. The finding of increased glutaminase activity in kidney tissue obtained from potassiumdeficient animals (33, 34) suggests that similar increases in glutaminase (or other enzymes) activity resulting in increased ammonia production may be operative in this circumstance in man. It is also possible that renal ammonia production is unaltered by potassium deficiency, but that availability of ammonia produced in tubular cells is affected by the presence or absence of potassium, which influences permeability of tubular cell membranes. If the latter hypothesis applied, the observedincreases in glutaminase activity might represent compensation for the tendency of intracellular ammonia concentration to decrease due to increased passage of ammonia from the cells. A relative increase in urinary ammonium excretion in relation to urine pH has been demonstrated in potassium-deficient human subjects (26, 32, 35) . The data presented here demonstrate that this increase in ammonium excretion is attributable to increased renal ammonia production or to increased availability of ammonia from tubular cells.
The applied significance of our findings can be summarized briefly as follows. Renal ammonium metabolism is altered in patients rendered acutely deficient of potassium. As a result of increased renal ammonia production or availability of ammonia in renal cells, the diffusion of ammonia into urine and renal venous blood is increased. This accounts for the increased urinary ammonium excretion at a given urine pH that occurs in potassium-deficient patients. In patients with normal hepatic function, the ammonium that diffuses into the renal vein is promptly synthesized into urea. The urea originating from this source may contribute to increases in blood urea nitrogen concentration that occur in some patients who are potassium depleted, especially if renal disease coexists or if dehydration limits glomerular filtration. In patients with hepatic disease the ammonium reaching the systemic circulation from the renal vein is not removed adequately by way of urea synthesis. This is reflected in increased arterial blood ammonium levels that occur in relation to hypokalemia. This internal ammonium load may precipitate the syndrome of impending hepatic com-a in susceptible patients. In these instances reversibility of the biochemical and clinical phenomena described depends upon the administration of potassium, which operates in some unknown fashion to decrease availability of ammonium from the kidney.
Most of the data reported here concern patients with hepatic disease and normal kidney function who were rendered acutely deficient of potassium by a mercurial diuretic regimen. It seems probable, however, that similar mechanisms may operate in patients rendered potassium deficient by other diuretic agents, by dietary potassium restriction, or as a result of extrarenal losses of potassium secondary to chronic vomiting or diarrhea.
SUMM ARY
The relation of acute potassium depletion resulting from a mercurial diuretic regimen to renal ammonium metabolism was evaluated in patients with cirrhosis of the liver and ascites.
The mercurial diuretic caused significant potassium deficits. Decreases in serum potassium concentration occurred that were followed by and reciprocally related to increases in arterial blood ammonium concentrations. Correction of potassium-i deficits by diet or by oral potassium supplements was followed by return of blood ammonium levels to control values.
The kidney was investigate(l as the possible source of the increased concentrations of circulating ammonium found in the potassium-deficient patients. Arterial, and peripheral and renal venous blood samples were obtained by catheterization techniques before and after induction of potassium deficiency. The greatest increases in ammonium concentration occurred in renal venous blood. Extremities. liver, and brain did not contribute ammonium to the circulation. With the intravenous administration of potassium gluconate to deficient subjects, renal venous blood ammonium concentrations and urinary ammonium excretions promptly decreased; ammonium was not diverted from renal venous outflow to urine.
In susceptible patients with liver disease who are rendered potassium deficient, ammonium delivered to the systemic circulation from kidney may precipitate the impending hepatic coma syndrome.
Our findings demonstrate that renal production of ammonium or its availability to tubular fluid and to renal venous outflow is increased in potassium-deficient patients. This influence of potassium in the regulation of ammonium metabolism by the kidney may explain the alterations in ammonium and urea nitrogen metabolism that occur in some potassium-deficient subjects with or without hepatic disease.
